Laboratory evaluation of the inflammatory myopathies.

Por Rider, L G, Miller, F W
Publicado em 1995

Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group.

Por Sainsbury, R., Rider, L., Smith, A., MacAdam, A.
Publicado em 1995

High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status?

Por Varghese, C., Barrett, J. H., Johnston, C., Shires, M., Rider, L., Forman, D.
Publicado em 1996

Modes of action of aspirin-like drugs.

Por Abramson, S, Korchak, H, Ludewig, R, Edelson, H, Haines, K, Levin, R I, Herman, R, Rider, L, Kimmel, S, Weissmann, G
Publicado em 1985

Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies

Por Rider, L G, Artlett, C M, Foster, C B, Ahmed, A, Neeman, T, Chanock, S J, Jimenez, S A, Miller, F W
Publicado em 2000

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis

Por Harris-Love, M. O., Shrader, J. A., Koziol, D., Pahlajani, N., Jain, M., Smith, M., Cintas, H. L., McGarvey, C. L., James-Newton, L., Pokrovnichka, A., Moini, B., Cabalar, I., Lovell, D. J., Wesley, R., Plotz, P. H., Miller, F. W., Hicks, J. E., Rider, L. G.
Publicado em 2009